InvestorsHub Logo
Followers 839
Posts 120502
Boards Moderated 18
Alias Born 09/05/2002

Re: rajaram46 post# 361

Thursday, 04/10/2014 4:07:30 PM

Thursday, April 10, 2014 4:07:30 PM

Post# of 3233
Not much, if at all, because my assumptions vis-à-vis ABBV/ENTA’s 3-DAA regimen have been quite conservative.

The most direct impact of MRK’s phase-2 data on the components in my sum-of-parts valuation model (#msg-94993406) is on the $50M I ascribed to ABBV/ENTA’s next-generation 2-DAA regimen of ABT-493 + ABT-530, which might have to be downgraded slightly; however, this is tantamount to round-off error in the overall scheme of things.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News